Temozolomide 25 mg | Purity Not Available
StressMarq Biosciences
Temozolomide
Search Results
(±)11(12)-DiHET-d11 50 µg | ≥99%
Cayman Chemical
(±)11(12)-DiHET-d11
(±)11(12)-DiHET-d11 25 µg | ≥99%
Cayman Chemical
(±)11(12)-DiHET-d11
(±)11(12)-DiHETE 100 µg | ≥98%
Cayman Chemical
(±)11(12)-DiHETE
(±)11(12)-DiHETE 50 µg | ≥98%
Cayman Chemical
(±)11(12)-DiHETE
(±)11(12)-DiHETE 25 µg | ≥98%
Cayman Chemical
(±)11(12)-DiHETE
(±)11(12)-EET 500 µg | ≥95%
Cayman Chemical
(±)11(12)-EET
(±)11(12)-EET 100 µg | ≥95%
Cayman Chemical
(±)11(12)-EET
(±)11(12)-EET 50 µg | ≥95%
Cayman Chemical
(±)11(12)-EET
(±)11(12)-EET 25 µg | ≥95%
Cayman Chemical
(±)11(12)-EET
(±)11(12)-EET Please inquire | ≥95%
BOC Sciences
11, 12-Epoxyeicosatrienoic acid is an epoxyeicosatrienoic acid (EET). Induction of CYP2C8 in native coronary artery endothelial cells by beta-naphthoflavone enhances the formation of 11, 12-epoxyeicosatrienoic acid, as well as endothelium-derived hyperpolarizing factor-mediated hyperpolarization and relaxatioocoagulation. It also has anti-inflammatory, angiogenic, and cardioprotective properties.
More Information Supplier Page